Faculty Information - 武田　志帆

（Last updated : 2022-05-26 17:06:04）

武田　志帆
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Internal Medicine, Division of Nephrology

Position Assistant Professor

■ Published papers

1.	Original article	Mutation Type and Intracranial Aneurysm Formation in Autosomal Dominant Polystic Kidney Disease 2022/05/20
2.	Original article	Initial decline in eGFR to predict tolvaptan response in autosomal-dominant polycystic kidney disease 2022/01/29
3.	Original article	Germline Mutations for Kidney Volume in ADPKD 2021/12/13
4.	Original article	Urinary Aquaporin 2 as a Potential Indicator Predicting Tolvaptan Response in Patients With ADPKD 2021/07/14
5.	Original article	Dose-Dependent Effect of Tolvaptan on Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease 2021/07
6.	Original article	Predicting liver cyst severity by mutations in patients with autosomal-dominant polycystic kidney disease 2021/04/02
7.	Original article	Impact of visceral fat area in patients with chronic kidney desease 2021/02/17
8.	Original article	Sex Differences in Time-Series Changes in Pseudo-R²　Values Regarding Hyperuricemia in Relation to the Kidney Prognosis 2020/11/26
9.	Original article	Visceral to subcutaneous fat ratio as an indicator of a ≧30％　eGFR decline in chronic kidney disease 2020/11
10.	Original article	Maximum Carotid Intima-Media Thickness in Association with Renal Outcomes 2020/08
11.	Original article	Urinary Mulberry Cells as a Biomarker of the Efficacy of Enzyme Replacement Therapy for Fabry Disease. 2020/04
12.	Original article	High Serum Phosphate Level as a Risk Factor to Determine Renal Prognosis in Autosomal Dominant Polycystic Kidney Disease: A Retrospective Study 2020/03/10
13.	Original article	Association between anemia and renal prognosis in autosomal dominant polycystic kidney disease: a retrospective study. 2020/02/08
14.	Original article	Prediction of Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease Using PKD1/PKD2 Mutations. 2020/01/05
15.	Original article	Proximal Tubulopathy With Fibrillary Inclusions: A Rare Manifestation of Lymphoma-Associated Monoclonal Gammopathy of Renal Significance(MGRS) 2019/10/17
16.	Original article	Glomerular Basement Membrane Protein Expression and the Diagnosis and Prognosis of Autosomal Dominant Alport Syndrome 2019/08/20
17.	Original article	Mutation analyses by next-generation sequencing and multiplex ligation-dependent probe amplification in Japanese autosomal dominant polycystic kidney disease patients 2019/04
18.	Original article	PKD1 mutation may epistatically ameliorate nephronophthisis progression in patients with NPHP1 deletion 2019/01
19.	Original article	Successful entecavir plus prednisolone treatment for hepatitis B virus-associated membranoproliferative glomerulonephritis:A case report. 2019/01
20.	Original article	Successful treatment with steroid and cyclosporine A in a patient with immunoglobulin A-proliferative glomerulonephritis with monoclonal immunoglobulin deposits. 2018/12
21.	Original article	Comparison of the response of frequently relapsing steroid-dependent minimal change nephrotic syndrome to retuximab therapy between childhood-onset and adult-onset disease. 2018/10
22.	Original article	Elevation of the serum liver enzyme levels during tolvaptan treatment in patients with autosomal dominant polycystic kidney disease (ADPKD). 2018/10
23.	Original article	Autosomal Dominant Polycystic Kidney Disease with Emphysematous Polycystic Renal Infection That Repuired Surgical Treatment 2018/08
24.	Original article	A case of unilateral nephrectomy performed for autosomal dominant polycystic kidney disease with marked unilateral enlargement. 2018/05
25.	Original article	New Insights into Cystic Kidney Diseases. 2018/05
26.	Original article	Successful treatment with steroid and cyclosporine A in a patient with immunoglobulin A-proliferative glomerulonephritis with monoclonal immunoglobulin deposits. 2018/03
Display 5 items
Display all(26)

■ Academic conference presentation

1.	Relationship of tolvaptan dose with the rate of decline in kidney function in ADPKD patients. 2019/11/07
2.	Elevation of the liver enzyme levels during tolvaptan treatment with autosomal dominant polycystic kidney disease (ADPKD) 2018/02/22